Literature DB >> 11336555

Two regions of the P protein are required to be active with the L protein for human parainfluenza virus type 1 RNA polymerase activity.

T Bousse1, T Takimoto, T Matrosovich, A Portner.   

Abstract

The paramyxovirus P protein is an essential component of the viral RNA polymerase composed of P and L proteins. In this study, we characterized the physical and functional interactions between P and L proteins using human parainfluenza virus type 1 (hPIV1) and its counterpart Sendai virus (SV). The hPIV1 P and SV L proteins or the SV P and hPIV1 L proteins formed complexes detected by anti-P antibodies. Functional analysis using the minigenome SV RNA containing CAT gene indicated that the hPIV1 P--SV L complex, but not the SV P--hPIV1 L complex, was biologically active. Mutant SV P or hPIV1 P cDNAs, which do not express C proteins, showed the same phenotype with wild-type P cDNAs, indicating that C proteins are not responsible for the dysfunction of SV P--hPIV1 L polymerase complex. Using the chimeric hPIV1/SV P cDNAs, we identified two regions (residues 387--423 and 511--568) on P protein, which are required for the functional interaction with hPIV1 L. These regions overlap with a previously identified domain for oligomer formation and binding to nucleocapsids. Our results indicate that in addition to a P--L binding domain, hPIV1 L requires a specific region on P protein to be biologically functional as a polymerase. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336555     DOI: 10.1006/viro.2001.0881

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  The C-terminal 88 amino acids of the Sendai virus P protein have multiple functions separable by mutation.

Authors:  Jeffery Tuckis; Sherin Smallwood; Joyce A Feller; Sue A Moyer
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.

Authors:  Irina V Alymova; Allen Portner; Toru Takimoto; Kelli L Boyd; Y Sudhakara Babu; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.

Authors:  Wenbin Wang; Xudong Chang; Wei Yao; Ning Wei; Na Huo; Yanhong Wang; Qiaolin Wei; Haijin Liu; Xinglong Wang; Shuxia Zhang; Zengqi Yang; Sa Xiao
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 4.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

5.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

6.  Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.

Authors:  Irina V Alymova; Garry Taylor; Toru Takimoto; Tsu-Hsing Lin; Pooran Chand; Y Sudhakara Babu; Chenghong Li; Xiaoping Xiong; Allen Portner
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction.

Authors:  Tatiana Bousse; Tatyana Matrosovich; Allen Portner; Atsushi Kato; Yoshiyuki Nagai; Toru Takimoto
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Regulation of measles virus gene expression by P protein coiled-coil properties.

Authors:  Louis-Marie Bloyet; Antoine Schramm; Carine Lazert; Bertrand Raynal; Maggy Hologne; Olivier Walker; Sonia Longhi; Denis Gerlier
Journal:  Sci Adv       Date:  2019-05-08       Impact factor: 14.136

9.  Identification of functional domains of phosphoproteins of two morbilliviruses using chimeric proteins.

Authors:  Paramananda Saikia; M S Shaila
Journal:  Virus Genes       Date:  2008-04-22       Impact factor: 2.198

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.